MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $15,706,000 | -59.7% | 1,125,900 | -46.6% | 0.20% | -46.6% |
Q3 2017 | $39,018,000 | +9.5% | 2,109,068 | 0.0% | 0.37% | -0.3% |
Q2 2017 | $35,643,000 | +26.6% | 2,109,068 | 0.0% | 0.37% | +17.2% |
Q1 2017 | $28,156,000 | -36.6% | 2,109,068 | -28.6% | 0.32% | -43.6% |
Q4 2016 | $44,427,000 | – | 2,951,968 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 3,500,000 | $45,360,000 | 2.38% |
Palo Alto Investors LP | 1,757,122 | $22,772,000 | 1.52% |
Greencape Capital Pty Ltd | 270,280 | $3,503,000 | 1.24% |
GREAT POINT PARTNERS LLC | 1,000,000 | $12,960,000 | 1.19% |
Ghost Tree Capital, LLC | 350,000 | $4,536,000 | 1.16% |
Perceptive Advisors | 2,905,000 | $37,649,000 | 1.01% |
Eventide Asset Management | 1,236,000 | $16,019,000 | 0.53% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 80,000 | $1,036,000 | 0.48% |
PEREGRINE CAPITAL MANAGEMENT LLC | 832,627 | $10,791,000 | 0.29% |
Rock Springs Capital Management LP | 400,000 | $5,184,000 | 0.21% |